These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33047822)

  • 1. Imposed mutational meltdown as an antiviral strategy.
    Jensen JD; Stikeleather RA; Kowalik TF; Lynch M
    Evolution; 2020 Dec; 74(12):2549-2559. PubMed ID: 33047822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
    Jensen JD; Lynch M
    Heredity (Edinb); 2020 May; 124(5):619-620. PubMed ID: 32251365
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic diversity and molecular dynamics interaction on mutational variances among RB domains of SARS-CoV-2 interplay drug inactivation.
    Uddin MB; Sajib EH; Hoque SF; Bappy MNI; Elahi F; Ghosh A; Muhit S; Hassan MM; Hasan M; Chelliah R; Park SJ; Mony TJ; Oh DH; Ahmed SSU
    Infect Genet Evol; 2022 Jan; 97():105128. PubMed ID: 34752930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal mutagenesis as an antiviral strategy.
    Swanstrom R; Schinazi RF
    Science; 2022 Feb; 375(6580):497-498. PubMed ID: 35113690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.
    Azgari C; Kilinc Z; Turhan B; Circi D; Adebali O
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33801257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
    Salpini R; Alkhatib M; Costa G; Piermatteo L; Ambrosio FA; Di Maio VC; Scutari R; Duca L; Berno G; Fabeni L; Alcaro S; Ceccherini-Silberstein F; Artese A; Svicher V
    J Antimicrob Chemother; 2021 Jan; 76(2):396-412. PubMed ID: 33254234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
    Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2.
    Amoutzias GD; Nikolaidis M; Tryfonopoulou E; Chlichlia K; Markoulatos P; Oliver SG
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.
    Cheng K; Martin-Sancho L; Pal LR; Pu Y; Riva L; Yin X; Sinha S; Nair NU; Chanda SK; Ruppin E
    Mol Syst Biol; 2021 Nov; 17(11):e10260. PubMed ID: 34709707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
    Younis NK; Zareef RO; Maktabi MAN; Mahfouz R
    Genet Test Mol Biomarkers; 2021 Feb; 25(2):85-101. PubMed ID: 33596144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could a popular antiviral supercharge the pandemic?
    Service RF
    Science; 2023 Feb; 379(6632):526. PubMed ID: 36758089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiscale Feedback Loops in SARS-CoV-2 Viral Evolution.
    Barrett C; Bura AC; He Q; Huang FW; Li TJX; Waterman MS; Reidys CM
    J Comput Biol; 2021 Mar; 28(3):248-256. PubMed ID: 33275493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
    Fareh M; Zhao W; Hu W; Casan JML; Kumar A; Symons J; Zerbato JM; Fong D; Voskoboinik I; Ekert PG; Rudraraju R; Purcell DFJ; Lewin SR; Trapani JA
    Nat Commun; 2021 Jul; 12(1):4270. PubMed ID: 34257311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Based on Principles and Insights of COVID-19 Epidemiology, Genome Sequencing, and Pathogenesis: Retrospective Analysis of Sinigrin and Prolixin
    Nazeam J; Mohammed EZ; Raafat M; Houssein M; Elkafoury A; Hamdy D; Jamil L
    SLAS Discov; 2020 Dec; 25(10):1123-1140. PubMed ID: 32804597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Discovery, diagnostics and drug development.
    Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
    J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.
    Rahimi A; Mirzazadeh A; Tavakolpour S
    Genomics; 2021 Jan; 113(1 Pt 2):1221-1232. PubMed ID: 33007398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target.
    Renz A; Widerspick L; Dräger A
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34073716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.